Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Oct 31, 2012

Filed with the SEC on Dec 13, 2012 and accepted by EDGAR at Dec 13, 2012, 14:52 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-10-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2012-08-01 to 2012-10-31$436.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2012-05-01 to 2012-10-31$823.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2012-08-01 to 2012-10-31−$1.9mus-gaap:OperatingIncomeLoss
Operating income6 months2012-05-01 to 2012-10-31−$3.5mus-gaap:OperatingIncomeLoss
Net income3 months2012-08-01 to 2012-10-31−$2.0mus-gaap:NetIncomeLoss
Net income6 months2012-05-01 to 2012-10-31−$3.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2012-08-01 to 2012-10-31−$0.04us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2012-05-01 to 2012-10-31−$0.07us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2012-05-01 to 2012-10-31−$2.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2012-05-01 to 2012-10-31$28.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-10-31$2.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-10-31$2.9mus-gaap:AssetsCurrent
Total assetsAt period end2012-10-31$4.2mus-gaap:Assets
Current liabilitiesAt period end2012-10-31$2.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-10-31$3.3mus-gaap:Liabilities
Shareholders' equityAt period end2012-10-31−$7.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-12-067797. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.